Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
3 May 24
8-K
Regulation FD Disclosure
12 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
8-K
Berubicin study enrollment completed; Topline data expected in first half of 2025
1 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
PRE 14A
Preliminary proxy
28 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Feb 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
21 Feb 24
8-K
Entry into a Material Definitive Agreement
2 Feb 24
424B4
Prospectus supplement with pricing info
31 Jan 24
EFFECT
Notice of effectiveness
30 Jan 24
CORRESP
Correspondence with SEC
26 Jan 24
CORRESP
Correspondence with SEC
26 Jan 24
CORRESP
Correspondence with SEC
25 Jan 24
CORRESP
Correspondence with SEC
25 Jan 24
CORRESP
Correspondence with SEC
24 Jan 24
CORRESP
Correspondence with SEC
24 Jan 24
8-K
Departure of Directors or Certain Officers
23 Jan 24
S-1/A
IPO registration (amended)
22 Jan 24
CORRESP
Correspondence with SEC
18 Jan 24
CORRESP
Correspondence with SEC
18 Jan 24
CORRESP
Correspondence with SEC
16 Jan 24
CORRESP
Correspondence with SEC
16 Jan 24
S-1/A
IPO registration (amended)
10 Jan 24
CORRESP
Correspondence with SEC
26 Dec 23
CORRESP
Correspondence with SEC
26 Dec 23
8-K
Regulation FD Disclosure
21 Dec 23
CORRESP
Correspondence with SEC
21 Dec 23
CORRESP
Correspondence with SEC
21 Dec 23
CORRESP
Correspondence with SEC
21 Dec 23
CORRESP
Correspondence with SEC
21 Dec 23
CORRESP
Correspondence with SEC
20 Dec 23
CORRESP
Correspondence with SEC
20 Dec 23
CORRESP
Correspondence with SEC
20 Dec 23
CORRESP
Correspondence with SEC
20 Dec 23
8-K
CNS Pharmaceuticals Announces Successful Interim Analysis of Efficacy
18 Dec 23
CORRESP
Correspondence with SEC
14 Dec 23
CORRESP
Correspondence with SEC
14 Dec 23
UPLOAD
Letter from SEC
13 Dec 23
S-1
IPO registration
8 Dec 23
Latest ownership filings
4
Amy Mahery
10 Apr 24
4
Jeffry R. Keyes
10 Apr 24
4
Jerzy Gumulka
10 Apr 24
4
Carl Anthony Evans
10 Apr 24
4
Christopher Downs
10 Apr 24
4
Bettina M. Cockroft
10 Apr 24
4
John M Climaco
10 Apr 24
4
Faith L. Charles
10 Apr 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Amy Mahery
6 Feb 24
4
Jerzy Gumulka
6 Feb 24
4
Carl Anthony Evans
6 Feb 24
4
Christopher Downs
6 Feb 24
4
John M Climaco
6 Feb 24
3
Amy Mahery
6 Feb 24
4/A
Jerzy Gumulka
12 Oct 23
4/A
Carl Anthony Evans
12 Oct 23
4/A
Jeffry R. Keyes
12 Oct 23
4/A
Bettina M. Cockroft
12 Oct 23
4/A
Faith L. Charles
12 Oct 23
4/A
Andrzej Andraczke
12 Oct 23
4
Jeffry R. Keyes
25 Sep 23
4
Jerzy Gumulka
25 Sep 23
4
Carl Anthony Evans
25 Sep 23
4
Bettina M. Cockroft
25 Sep 23
4
Faith L. Charles
25 Sep 23
4
Andrzej Andraczke
25 Sep 23
4
Christopher Downs
23 Aug 23
4
John M Climaco
16 Aug 23
4/A
Bettina M. Cockroft
10 Aug 23
4
Waldemar Priebe
1 Aug 23
SC 13G
Priebe Waldemar
1 Aug 23
4
Bettina M. Cockroft
9 May 23
3
Bettina M. Cockroft
9 May 23
4
John M Climaco
1 May 23
4
Christopher Downs
1 May 23
4
Jerzy Gumulka
21 Apr 23
4
Christopher Downs
18 Apr 23
4
Jerzy Gumulka
17 Apr 23
4
John M Climaco
14 Apr 23